ClinicalTrials.gg
RecruitingNCT04237675Updated Jan 23, 2020

Postoperative Relapses in MS Patients

An observational study in Multiple Sclerosis Relapse, Surgery and Anesthesia, sponsored by University of Athens. Recruiting at 2 sites in Greece. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-01-23.

Sponsored by University of Athens · Observational

How we know

From the registry’s dates

  • Started Dec 2019; still recruiting 6 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Multiple Sclerosis with a site in Greece — 6 open to participants now, 17 under way, 8 of them phase 3. Multiple Sclerosis · Greece.

Planned enrollment
6th of 14
300 · median 255
Started
2019
with 4 others
Observational
14 of 69
3 open now
Primary completion
2027-12
later than 9 of 16 live
Registered
43rd of 69
by date

Among the 69 studies in Multiple Sclerosis with a site in Greece, this one is the 6th largest by planned enrollment of the 14 observational ones that give a count, is one of 5 that started in 2019, is one of 14 observational ones, reaches primary completion later than 9 of the 16 other live ones, and was the 43rd registered.

Multiple Sclerosis

3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

6 of the 69 studies in Multiple Sclerosis with a site in Greece are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →

Who these studies take

Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Multiple Sclerosis with a site in Greece, or all of them as a file.
02

Study summary

The aim of the study is to record any relapses during one year postoperatively in patients and parturients diagnosed with MS who received general or regional anesthesia

03

Conditions studied

  • Multiple Sclerosis Relapse
  • Surgery
  • Anesthesia

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients or parturients with MS who received general or regional anesthesia for surgery or labor analgesia

Eligibility criteria

Inclusion Criteria: diagnosed MS -

Exclusion Criteria: refuse to participate

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • regional anesthesia

    Procedure: surgery and anesthesia

  • general anesthesia

    Procedure: surgery and anesthesia

Interventions

  • Proceduresurgery and anesthesia

    patients with MS who received general or regional anesthesia for a surgery or labor

06

What researchers measure

Primary outcomes

  1. MS relapses

    number of relapses

    Time frame: one year postoperatively

07

Study locations

2 of 2 sites recruiting
  • Aretaieio Hospital, University of Athens
    Athens, Attiki 11528, Greece
    Recruiting
    • Chryssoula V Staikou, MD · Contactc_staikou@yahoo.gr · +210 7286172
    • Chryssoula V Staikou, MD, DESA · Principal investigator
  • Aretaieio Hospital
    Athens, Greece
    Recruiting
    • Chryssoula V Staikou, Assoc Prof · Contact
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2019 (actual). Primary completion is estimated for Dec 2027, 96 months after the start.

Of 336 non-industry observational studies under Multiple Sclerosis, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 81. This study's planned 96 months is above that.

Counting every sponsor, half of 427 studies reached it within 41 months; a quarter within 15 and three quarters within 75.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2020
First posted
Jan 23, 2020
StartActual
Dec 20, 2019
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Jan 23, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04237675
Responsible party
Staikou Chryssoula (Associate Professor, University of Athens) — Principal investigator
First posted
Jan 23, 2020
Start date
Dec 20, 2019
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jan 23, 2020

Study contacts

Chryssoula V Staikou, Assoc Prof
Contact
c_staikou@yahoo.gr
00302107780172

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion